Detailed Information on Publication Record
2003
Inhibition of cannabinoid CB1 receptor attenuates behavioural sensitization to methamphetamine in mice
LANDA, Leoš, Karel ŠLAIS and Alexandra ŠULCOVÁBasic information
Original name
Inhibition of cannabinoid CB1 receptor attenuates behavioural sensitization to methamphetamine in mice
Authors
LANDA, Leoš (203 Czech Republic), Karel ŠLAIS (203 Czech Republic) and Alexandra ŠULCOVÁ (203 Czech Republic, guarantor)
Edition
European Neuropsychopharmacology, Amsterdam, Elsevier, 2003, 0924-977X
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Netherlands
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 2.842
RIV identification code
RIV/00216224:14110/03:00008970
Organization unit
Faculty of Medicine
UT WoS
000185412300676
Keywords in English
AM 251; behavioral sensitization; locomotor/exploratory activity; mice
Tags
International impact
Změněno: 30/11/2006 13:23, doc. Mgr. MVDr. Leoš Landa, Ph.D.
Abstract
V originále
Behavioural sensitization is typically manifested by increased behavioural responses to the drug. In our previous studies we created an original dosage regimen that produced sensitization to methamphetamine effects on locomotor/exploratory behaviour in mice and also cross-sensitization to methamphetamine with the cannabinoid receptor agonist methanandamide. The changes in the behaviour were recorded in the open field of the Actitrack apparatus (Panlab, S. L., Spain). Methamphetamine and combined methamphetamine+AM 251 treatments were injected to the mice at the doses of 2.5 mg/kg and 5 mg/kg, respectively. On the day 8 all mice were given a "challenge dose" of methamphetamine 2.5 mg/kg to check a development of hypothesised sensitization. In the group pre-treated with methamphetamine only, a significant behavioural sensitization occurred, whereas in the group pre-treated with the combination of methamphetamine and selective CB1 receptor antagonist AM 251 behavioural responses were significantly lower compared to methamphetamine sensitized animals.